US: Trump announces further agreements to lower drug prices
The White House is talking about "enormous discounts" that the pharmaceutical companies want to give US costs. However, consumer protection organizations are expressing skepticism.
US President Donald Trump has announced new agreements with several pharmaceutical companies to lower medication prices. The companies, including CSL, Sun Pharmaceutical, and UCB, have agreed to offer medications to the Medicaid healthcare program at best-possible prices. Trump described this as an "enormous discount" that will significantly reduce healthcare costs.
The exact number of medications and savings involved are unclear. This follows similar deals with 17 major pharmaceutical companies, including Pfizer, Eli Lilly, and Novo Nordisk, last year.
Written by urgent.news from Handelsblatt's report — not a translation of it. Machine-written — may contain errors; check the original before relying on it.
